Ibrahim Nagmeldin Hassan

Dr. Ibrahim Nagmeldin Hassan

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
IHIbrahim Nagmeldin Hassan
Ibrahim Nagmeldin Hassan
NANagmeldin Abuassa
Nagmeldin Abuassa
MIMohamed Ibrahim
Mohamed Ibrahim
The Sudan conflict has created a severe humanitarian crisis, displacing millions and crippling the healthcare system, leading to a resurgence of infectious diseases such as malaria, cholera, and measles. Overcrowded refugee camps with poor sanitation and limited resources have fueled outbreaks, exacerbated by disrupted immunization programs and seasonal rains. Malaria is spreading rapidly due to inadequate mosquito control, while cholera outbreaks, linked to unsafe water and poor sanitation, have overwhelmed health facilities. Measles outbreaks are escalating due to low vaccination coverage, leaving vulnerable populations unprotected. The regional and global impacts are significant, as displaced populations crossing borders risk spreading diseases. Addressing this crisis requires urgent international collaboration to restore healthcare services, improve living conditions in camps, resume vaccination programs, and strengthen regional disease surveillance. Timely, coordinated responses are essential to mitigate health risks and protect global health security. This crisis highlights the critical need for sustained efforts to safeguard public health in conflict zones.

15 July 2025 in Clinical Cardiology
Verified
Journal Article
Open access
IHIbrahim Nagmeldin Hassan
Ibrahim Nagmeldin Hassan
MIMohamed Ibrahim
Mohamed Ibrahim
SYSiddig Yaqub
Siddig Yaqub
MIMuhsin Ibrahim
Muhsin Ibrahim
HAHaythem Abdalla
Haythem Abdalla
MSMaryam Shoukat
Maryam Shoukat
Background: Atrial fibrillation (AF) and obstructive sleep apnea (OSA) frequently coexist and synergistically increase cardiovascular risk. While their pathophysiologic interplay is well established, national data on mortality trends involving both conditions are scarce.Methods: We analyzed mortality data from the CDC WONDER platform (1999–2020), including adults aged ≥ 25 years with AF (ICD‐10 I48.x) listed as the underlying cause of death and OSA (G47.33) as a contributing condition. Age‐adjusted mortality rates (AAMRs) and average annual percent changes (AAPCs) were calculated using Joinpoint regression, stratified by sex, race/ethnicity, urbanization, region, and age.Results: A total of 32,142 AF‐related deaths with OSA were identified. The overall AAMR was 0.60 per 100 000, increasing significantly over time (AAPC: 16.69%, 95% CI: 15.62–17.77). Mortality rose across all demographic groups, with the steepest increases among adults ≥ 85 years (AAPC: 19.40%), females (AAPC: 17.77%), rural residents (AAPC: 17.51%), and White individuals (AAPC: 16.95%). Regionally, the Midwest (AAMR: 0.79) and West (0.72) had the highest rates. State‐level variation ranged from 1.90 (Oregon) to 0.19 (Mississippi). Despite lower absolute AAMRs among Hispanic and Asian populations, significant upward trends were observed. OSA appears frequently underdiagnosed or untreated in high‐risk groups, potentially exacerbating AF mortality.Conclusions: AF‐related mortality involving OSA has risen sharply over the past two decades, outpacing many other cardiovascular trends. These findings underscore the urgent need for integrated AF‐OSA screening and treatment pathways, with attention to underserved and disproportionately affected populations.

14 May 2025 in Clinical Cardiology
Verified
Journal Article
Open access
HAHamza Ashraf
Hamza Ashraf
ZNZain Ali Nadeem
Zain Ali Nadeem
KRKhawaja Abdul Rehman
Khawaja Abdul Rehman
SAShanzay Akhtar
Shanzay Akhtar
HAHaider Ashfaq
Haider Ashfaq
RARaheel Ahmed
Raheel Ahmed
Background: Infective endocarditis (IE) is a life‐threatening infection requiring prolonged intravenous antimicrobial therapy. Outpatient parenteral antibiotic therapy (OPAT) has emerged as an alternative to prolonged hospitalization, but its safety and efficacy in IE remain debated.Hypothesis: This systematic review and meta‐analysis aimed to evaluate the outcomes of OPAT in IE patients.Methods: We systematically searched MEDLINE, Cochrane CENTRAL, Google Scholar, and Scopus for studies assessing OPAT in IE. Eligible studies included randomized controlled trials and observational studies reporting at least one relevant outcome (mortality, relapse, readmission, valve surgery, and adverse events). Pooled estimates were calculated using a random‐effects model, and heterogeneity was assessed using the I² statistic. Risk of bias was evaluated using the ROBINS‐I tool.Results: A total of 25 studies involving 2654 patients were included in the analysis. Patients treated with OPAT had a mortality rate of 0% during the treatment period and 5% during follow‐up. The readmission rate was 16% during the treatment period, 4% of the patients had relapse, while 16% of patients underwent cardiac surgery. During follow‐up, the readmission rate was 19%, with a relapse rate of 2%, and 14% of patients underwent cardiac surgery. Sensitivity analyses did not significantly affect the results, highlighting the robustness of the findings.Conclusion: OPAT appears to be safe and effective for IE patients, with low mortality and relapse rates. However, increased readmission rates and IV‐line complications warrant careful patient selection and monitoring. Further prospective trials are needed to refine OPAT protocols.

16 January 2025 in IDCases
Verified
Journal Article
Open access
IHIbrahim Nagmeldin Hassan
Ibrahim Nagmeldin Hassan
SYSiddig Yaqub
Siddig Yaqub
MIMohamed Ibrahim
Mohamed Ibrahim
GAGhada Aljaili
Ghada Aljaili
NANagmeldin Abuassa
Nagmeldin Abuassa
Dengue fever is a common viral illness in tropical and subtropical regions, typically presenting with fever, myalgia, and hemorrhagic symptoms. While neurological complications are rare, Guillain-Barré Syndrome (GBS) is a known but uncommon sequelae of viral infections, including dengue. We report the case of a previously healthy 32-year-old male who developed acute flaccid paralysis secondary to GBS following a dengue fever infection. The patient initially presented with classic dengue symptoms-fever, severe headache, retro-orbital pain, and myalgia. Following resolution of the acute dengue phase, he developed ascending muscle weakness, areflexia, and numbness in both legs. Electromyography confirmed a diagnosis of GBS, and cerebrospinal fluid analysis revealed albuminocytologic dissociation. The patient was treated with intravenous immunoglobulin (IVIG), leading to significant clinical improvement, with gradual recovery of motor function. This case highlights the rare but significant neurological complication of GBS following dengue fever. Clinicians should maintain a high index of suspicion for GBS in patients recovering from dengue, especially in endemic regions. Early diagnosis and treatment with IVIG or plasmapheresis are critical for improving outcomes in these patients. Dengue fever can lead to severe neurological sequelae such as GBS, and early recognition and intervention can prevent long-term disability. This case underscores the need for vigilance in identifying such complications in patients recovering from viral infections.

13 September 2024 in The Lancet
Verified
Journal Article
Closed access
IHIbrahim Nagmeldin Hassan
Ibrahim Nagmeldin Hassan
NANagmeldin Abuassa
Nagmeldin Abuassa
MIMohamed Ibrahim
Mohamed Ibrahim

24 October 2024 in High Blood Pressure & Cardiovascular Prevention
Verified
Journal Article
Closed access
PDF file
IHIbrahim Nagmeldin Hassan
Ibrahim Nagmeldin Hassan
NANagmeldin Abuassa
Nagmeldin Abuassa
MIMohamed Ibrahim
Mohamed Ibrahim